Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 34573 | 109 | 25.3 | 47% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 365 | 3 | MICROTUBULES//MITOSIS//KINETOCHORE | 34118 |
| 2644 | 2 | COMBRETASTATIN//COMBRETASTATIN A 4//VASCULAR DISRUPTING AGENTS | 3490 |
| 34573 | 1 | CI 980//1 ACETYLINDOLINE//ALPHA AMINOALKYL ARYL KETONE | 109 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CI 980 | authKW | 1494092 | 7% | 67% | 8 |
| 2 | 1 ACETYLINDOLINE | authKW | 280143 | 1% | 100% | 1 |
| 3 | ALPHA AMINOALKYL ARYL KETONE | authKW | 280143 | 1% | 100% | 1 |
| 4 | BROMOC 14BENZENE | authKW | 280143 | 1% | 100% | 1 |
| 5 | C 14CL 980 | authKW | 280143 | 1% | 100% | 1 |
| 6 | CHEM BIOL PROV FUJIAN | address | 280143 | 1% | 100% | 1 |
| 7 | CHIRAL ALPHA AMINOKETONE SYNTHON | authKW | 280143 | 1% | 100% | 1 |
| 8 | CHIRAL PROPIONYL CHLORIDE | authKW | 280143 | 1% | 100% | 1 |
| 9 | CL 980 | authKW | 280143 | 1% | 100% | 1 |
| 10 | CLIN INVESTSECT GYNECOL MED ONCOL | address | 280143 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Chemistry, Medicinal | 320 | 17% | 0% | 18 |
| 2 | Oncology | 305 | 28% | 0% | 31 |
| 3 | CYTOLOGY & HISTOLOGY | 145 | 2% | 0% | 2 |
| 4 | Cell Biology | 93 | 17% | 0% | 18 |
| 5 | Pharmacology & Pharmacy | 85 | 18% | 0% | 20 |
| 6 | Biochemistry & Molecular Biology | 48 | 21% | 0% | 23 |
| 7 | Chemistry, Organic | 31 | 9% | 0% | 10 |
| 8 | Toxicology | 28 | 6% | 0% | 6 |
| 9 | Physiology | 19 | 6% | 0% | 6 |
| 10 | Genetics & Heredity | 16 | 6% | 0% | 7 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CHEM BIOL PROV FUJIAN | 280143 | 1% | 100% | 1 |
| 2 | CLIN INVESTSECT GYNECOL MED ONCOL | 280143 | 1% | 100% | 1 |
| 3 | S BEND MICHIANA HEMATOL ONCOL | 280143 | 1% | 100% | 1 |
| 4 | CHENGDU DIAO PHARMACEUT GRP | 140071 | 1% | 50% | 1 |
| 5 | LUTHERAN GEN HOSP | 140071 | 1% | 50% | 1 |
| 6 | FT WAYNE MED | 93380 | 1% | 33% | 1 |
| 7 | PROC DEV CHEM ANALYT DEV | 56027 | 1% | 20% | 1 |
| 8 | PHASE COOPERAT NETWORK 2 | 40019 | 1% | 14% | 1 |
| 9 | ENGN CHEM MAT ENGN | 18674 | 1% | 7% | 1 |
| 10 | MELANOMA SARCOMA MED ONCOL | 18674 | 1% | 7% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | SOMATIC CELL GENETICS | 10956 | 3% | 1% | 3 |
| 2 | ANTI-CANCER DRUG DESIGN | 7141 | 4% | 1% | 4 |
| 3 | INVESTIGATIONAL NEW DRUGS | 2740 | 5% | 0% | 5 |
| 4 | JOURNAL OF MEDICINAL CHEMISTRY | 1300 | 9% | 0% | 10 |
| 5 | JOURNAL OF CELLULAR PHYSIOLOGY | 998 | 6% | 0% | 6 |
| 6 | RESEARCH COMMUNICATIONS IN SUBSTANCES OF ABUSE | 785 | 1% | 0% | 1 |
| 7 | CELL BIOLOGY INTERNATIONAL REPORTS | 652 | 2% | 0% | 2 |
| 8 | CANADIAN JOURNAL OF BIOCHEMISTRY AND CELL BIOLOGY | 565 | 1% | 0% | 1 |
| 9 | MUTATION RESEARCH | 547 | 4% | 0% | 4 |
| 10 | CANCER INVESTIGATION | 399 | 2% | 0% | 2 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CI 980 | 1494092 | 7% | 67% | 8 | Search CI+980 | Search CI+980 |
| 2 | 1 ACETYLINDOLINE | 280143 | 1% | 100% | 1 | Search 1+ACETYLINDOLINE | Search 1+ACETYLINDOLINE |
| 3 | ALPHA AMINOALKYL ARYL KETONE | 280143 | 1% | 100% | 1 | Search ALPHA+AMINOALKYL+ARYL+KETONE | Search ALPHA+AMINOALKYL+ARYL+KETONE |
| 4 | BROMOC 14BENZENE | 280143 | 1% | 100% | 1 | Search BROMOC+14BENZENE | Search BROMOC+14BENZENE |
| 5 | C 14CL 980 | 280143 | 1% | 100% | 1 | Search C+14CL+980 | Search C+14CL+980 |
| 6 | CHIRAL ALPHA AMINOKETONE SYNTHON | 280143 | 1% | 100% | 1 | Search CHIRAL+ALPHA+AMINOKETONE+SYNTHON | Search CHIRAL+ALPHA+AMINOKETONE+SYNTHON |
| 7 | CHIRAL PROPIONYL CHLORIDE | 280143 | 1% | 100% | 1 | Search CHIRAL+PROPIONYL+CHLORIDE | Search CHIRAL+PROPIONYL+CHLORIDE |
| 8 | CL 980 | 280143 | 1% | 100% | 1 | Search CL+980 | Search CL+980 |
| 9 | ENDOSTEAL PROLIFERATION | 280143 | 1% | 100% | 1 | Search ENDOSTEAL+PROLIFERATION | Search ENDOSTEAL+PROLIFERATION |
| 10 | ENZYME LEVELS ENDOGENOUS XENOBIOTIC | 280143 | 1% | 100% | 1 | Search ENZYME+LEVELS+ENDOGENOUS+XENOBIOTIC | Search ENZYME+LEVELS+ENDOGENOUS+XENOBIOTIC |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | RYAN, CW , SHULMAN, KL , RICHARDS, JM , KUGLER, JW , SOSMAN, JA , ANSARI, RH , VOKES, EE , VOGELZANG, NJ , (2000) CI-980 IN ADVANCED MELANOMA AND HORMONE REFRACTORY PROSTATE CANCER.INVESTIGATIONAL NEW DRUGS. VOL. 18. ISSUE 2. P. 187-191 | 10 | 91% | 3 |
| 2 | WHITEHEAD, RP , UNGER, JM , FLAHERTY, LE , ECKARDT, JR , TAYLOR, SA , DIDOLKAR, MS , SAMLOWSKI, W , SONDAK, VK , (2001) PHASE II TRIAL OF CI-980 IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMA AND NO PRIOR CHEMOTHERAPY - A SOUTHWEST ONCOLOGY GROUP STUDY.INVESTIGATIONAL NEW DRUGS. VOL. 19. ISSUE 3. P. 239-243 | 9 | 90% | 4 |
| 3 | KUNSCHNER, LJ , FINE, H , HESS, K , JAECKLE, K , KYRITSIS, AP , YUNG, WKA , (2002) CI-980 FOR THE TREATMENT OF RECURRENT OR PROGRESSIVE MALIGNANT GLIOMAS: NATIONAL CENTRAL NERVOUS SYSTEM CONSORTIUM PHASE I-II EVALUATION OF CI-980.CANCER INVESTIGATION. VOL. 20. ISSUE 7-8. P. 948-954 | 9 | 64% | 4 |
| 4 | BERNSTEIN, ML , BARUCHEL, S , DEVINE, S , MARKOGLOU, N , WAINER, IW , WILLIAMS, M , BLANEY, S , MOGHRABI, A , WINICK, N , VIETTI, T , (1999) PHASE I AND PHARMACOKINETIC STUDY OF CI-980 IN RECURRENT PEDIATRIC SOLID TUMOR CASES: A PEDIATRIC ONCOLOGY GROUP STUDY.JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. VOL. 21. ISSUE 6. P. 494-500 | 7 | 88% | 5 |
| 5 | PATEL, SR , BURGESS, MA , PAPADOPOLOUS, NE , SIDHU, G , GRAY, R , PLAGER, C , JENKINS, J , BENJAMIN, RS , (1998) PHASE II STUDY OF CI-980 (NSC 635370) IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED SOFT-TISSUE SARCOMAS.INVESTIGATIONAL NEW DRUGS. VOL. 16. ISSUE 1. P. 87-92 | 7 | 78% | 10 |
| 6 | ROWINSKY, EK , LONG, GS , NOE, DA , GROCHOW, LB , BOWLING, MK , SARTORIUS, SE , DONEHOWER, RC , (1997) PHASE I AND PHARMACOLOGICAL STUDY OF CI-980, A NOVEL SYNTHETIC ANTIMICROTUBULE AGENT.CLINICAL CANCER RESEARCH. VOL. 3. ISSUE 3. P. 401-407 | 7 | 78% | 15 |
| 7 | TEMPLE, C , RENER, GA , (1990) POTENTIAL ANTIMITOTIC AGENTS - SYNTHESIS OF SOME ETHYL BENZOPYRAZIN-7-YLCARBAMATES, ETHYL PYRIDO[3,4-B]PYRAZIN-7-YLCARBAMATES, AND ETHYL PYRIDO[3,4-E]-ASYM-TRIAZIN-7-YLCARBAMATES.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 33. ISSUE 11. P. 3044-3050 | 7 | 100% | 4 |
| 8 | TEMPLE, C , RENER, GA , (1992) ANTIMITOTIC AGENTS - CHIRAL ISOMERS OF ETHYL [5-AMINO-1,2-DIHYDRO-3-(4-HYDROXYPHENYL)-2-METHYLPYRIDO[3,4-B]PYRAZIN-7-YL]CARBAMATE.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 35. ISSUE 6. P. 988-993 | 7 | 88% | 4 |
| 9 | THOMAS, JP , MOORE, T , KRAUT, EH , BALCERZAK, SP , GALLOWAY, S , VANDRE, DD , (2002) A PHASE II STUDY OF CI-980 IN PREVIOUSLY UNTREATED EXTENSIVE SMALL CELL LUNG CANCER: AN OHIO STATE UNIVERSITY PHASE II RESEARCH CONSORTIUM STUDY.CANCER INVESTIGATION. VOL. 20. ISSUE 2. P. 192 -198 | 8 | 50% | 10 |
| 10 | BULLEN, WW , WHITFIELD, LR , WALTER, GA , BRODFUEHRER, JI , (1995) HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR CI-980, A NOVEL 1-DEAZA-7,8-DIHYDROPTERIDINE ANTICANCER AGENT, IN HUMAN PLASMA AND URINE.JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS. VOL. 668. ISSUE 1. P. 141-151 | 6 | 86% | 4 |
Classes with closest relation at Level 1 |